Evidence map›Paper›PMID 35508708›Full record

ArticleCommunications biology2022

GATA6 is predicted to regulate DNA methylation in an in vitro model of human hepatocyte differentiation.

Takahiro Suzuki, Erina Furuhata, Shiori Maeda, Mami Kishima, Yurina Miyajima, Yuki Tanaka, Joanne Lim, Hajime Nishimura, Yuri Nakanishi, Aiko Shojima and 1 more

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Takahiro SuzukiLaboratory for Cellular Function Conversion Technology, RIKEN Center for Integrated Medical Science (IMS), RIKEN Yokohama Campus, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama City, Kanagawa, 230-0045, Japan.ORCID 0000-0002-0972-6911
Erina Furuhata *Laboratory for Cellular Function Conversion Technology, RIKEN Center for Integrated Medical Science (IMS), RIKEN Yokohama Campus, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama City, Kanagawa, 230-0045, Japan.
Shiori Maeda *Laboratory for Cellular Function Conversion Technology, RIKEN Center for Integrated Medical Science (IMS), RIKEN Yokohama Campus, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama City, Kanagawa, 230-0045, Japan.
Mami KishimaLaboratory for Cellular Function Conversion Technology, RIKEN Center for Integrated Medical Science (IMS), RIKEN Yokohama Campus, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama City, Kanagawa, 230-0045, Japan.
Yurina MiyajimaLaboratory for Cellular Function Conversion Technology, RIKEN Center for Integrated Medical Science (IMS), RIKEN Yokohama Campus, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama City, Kanagawa, 230-0045, Japan.
Yuki TanakaLaboratory for Cellular Function Conversion Technology, RIKEN Center for Integrated Medical Science (IMS), RIKEN Yokohama Campus, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama City, Kanagawa, 230-0045, Japan.
Joanne LimLaboratory for Cellular Function Conversion Technology, RIKEN Center for Integrated Medical Science (IMS), RIKEN Yokohama Campus, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama City, Kanagawa, 230-0045, Japan.
Hajime NishimuraLaboratory for Cellular Function Conversion Technology, RIKEN Center for Integrated Medical Science (IMS), RIKEN Yokohama Campus, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama City, Kanagawa, 230-0045, Japan.
Yuri NakanishiLaboratory for Cellular Function Conversion Technology, RIKEN Center for Integrated Medical Science (IMS), RIKEN Yokohama Campus, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama City, Kanagawa, 230-0045, Japan.
Aiko ShojimaLaboratory for Cellular Function Conversion Technology, RIKEN Center for Integrated Medical Science (IMS), RIKEN Yokohama Campus, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama City, Kanagawa, 230-0045, Japan.
Harukazu SuzukiLaboratory for Cellular Function Conversion Technology, RIKEN Center for Integrated Medical Science (IMS), RIKEN Yokohama Campus, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama City, Kanagawa, 230-0045, Japan. harukazu.suzuki@riken.jp.ORCID 0000-0002-8087-0836
RIKEN Center for Integrative Medical Sciences · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatocytes are the dominant cell type in the human liver, with functions in metabolism, detoxification, and producing secreted proteins. Although gene regulation and master transcription factors involved in the hepatocyte differentiation have been extensively investigated, little is known about how the epigenome is regulated, particularly the dynamics of DNA methylation and the critical upstream factors. Here, by examining changes in the transcriptome and the methylome using an in vitro hepatocyte differentiation model, we show putative DNA methylation-regulating transcription factors, which are likely involved in DNA demethylation and maintenance of hypo-methylation in a differentiation stage-specific manner. Of these factors, we further reveal that GATA6 induces DNA demethylation together with chromatin activation in a binding-site-specific manner during endoderm differentiation. These results provide an insight into the spatiotemporal regulatory mechanisms exerted on the DNA methylation landscape by transcription factors and uncover an epigenetic role for transcription factors in early liver development.

Indexed as

DNA MethylationGATA6 Transcription FactorCell DifferentiationChromatin ImmunoprecipitationHepatocytesHumansGATA6 protein, humanGATA6 Transcription Factor

Identifiers

PMID35508708
PMCPMC9068788
OpenAlexW4225375005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.